{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-008301","form_type":"8-K","ticker":"SVRA","cik":"0001160308","company_name":"Savara Inc","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.626747+00:00","generated_at":"2026-05-16T11:01:59.057935+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Savara updates corporate presentation; no material new disclosures","bullets":["Corporate presentation posted on IR website and furnished as exhibit.","Reaffirms focus on rare respiratory diseases; no new clinical or financial data.","No changes to guidance, pipeline, or leadership disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-008301","json":"https://secwatch.observer/filing/0001193125-26-008301.json","markdown":"https://secwatch.observer/filing/0001193125-26-008301.md","text":"https://secwatch.observer/filing/0001193125-26-008301.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1160308/000119312526008301/0001193125-26-008301-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1160308/000119312526008301/d24211d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:01:59.057935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}